Evidence map›Paper›PMID 36315342›Full record

ArticleAdvances in therapy2023

Correction to: Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries.

Gregory R Fulcher, Shahid Akhtar, Saleh J Al-Jaser, Johan Medina, Mafauzy Mohamed, Nemencio A Nicodemus, Anne Helene Olsen, Kiran P Singh, Adri Kok

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 7 countries.

Gregory R FulcherDepartment of Diabetes, Endocrinology and Metabolism, Royal North Shore Hospital, Sydney, NSW, 2065, Australia. greg.fulcher@sydney.edu.au.ORCID http://orcid.org/0000-0001-8782-0420
Shahid AkhtarNovo Nordisk Region Asia Pacific, Dubai, United Arab Emirates.
Saleh J Al-JaserDepartment of Internal Medicine, Specialized Medical Center Hospital, Riyadh, Saudi Arabia.
Johan MedinaNovo Nordisk A/S, Søborg, Denmark.
Mafauzy MohamedDepartment of Medicine, Hospital Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia.
Nemencio A NicodemusDepartment of Biochemistry and Molecular Biology, University of the Philippines-College of Medicine, Manila, Philippines.
Anne Helene OlsenNovo Nordisk A/S, Søborg, Denmark.
Kiran P SinghDepartment of Endocrinology, Fortis Hospital, Mohali, Punjab, India.
Adri KokNetcare Union and Clinton Hospitals, Alberton, South Africa.
Novo Nordisk (Denmark) · DKFortis Hospital · INHospital Universiti Sains Malaysia · MYRiyadh Armed Forces Hospital · SAThe University of Sydney · AUUniversity of the Philippines Manila · PHUniversity of the Witwatersrand · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36315342
PMCPMC9859900
OpenAlexW4307775684

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.